Abstract
This paper reviews cellular and molecular mechanisms of gastrointestinal ulcer healing. Ulcer healing, a genetically programmed repair process, includes inflammation, cell proliferation, re-epithelialization, formation of granulation tissue, angiogenesis, interactions between various cells and the matrix and tissue remodeling, all resulting in scar formation. All these events are controlled by the cytokines and growth factors (EGF, PDGF, KGF, HGF, TGFβ, VEGF, angiopoietins) and transcription factors activated by tissue injury in spatially and temporally coordinated manner. These growth factors trigger mitogenic, motogenic and survival pathways utilizing Ras, MAPK, PI-3K/Akt, PLC-γ and Rho/Rac/actin signaling. Hypoxia activates pro-angiogenic genes (e.g., VEGF, angiopoietins) via HIF, while serum response factor (SRF) is critical for VEGF-induced angiogenesis, re-epithelialization and muscle restoration. EGF, its receptor, HGF and Cox2 are important for epithelial cell proliferation, migration re-epithelializaton and reconstruction of gastric glands. VEGF, angiopoietins, nitric oxide, endothelin and metalloproteinases are important for angiogenesis, vascular remodeling and mucosal regeneration within ulcer scar. Circulating progenitor cells are also important for ulcer healing. Local gene therapy with VEGF + Ang1 and/or SRF cDNAs dramatically accelerates esophageal and gastric ulcer healing and improves quality of mucosal restoration within ulcer scar. Future directions to accelerate and improve healing include the use of stem cells and tissue engineering.
Similar content being viewed by others
References
Cotran RS, Kumar V, Robbins SL: Gastric ulceration. In Robbins Pathologic Basis of Disease. 5th Edition. RS Cotran, V Kumar, SL Robbins (eds). Philadelphia, Saunders, 1999, pp 298–299, 773–777
Tarnawski A: Cellular mechanisms of gastric ulcer healing. In The Stomach. W Domschke, SJ Konturek (eds). Berlin New York, Springer, 1993, pp 177–192
Tarnawski A: Molecular mechanism of ulcer healing. Drug News Perspect 13:158–168, 2000
Tarnawski A, Hollander D, Stachura J, et al.: Vascular and microvascular changes—key factors in the development of acetic acid-induced gastric ulcers in rats. J Clin Gastroenterol 12(1):S148–S157, 1990
Baatar D, Kawanaka H, Szabo IL, Pai R, Jones MK, Kitano S, Tarnawski AS: Esophageal ulceration activates genes encoding keratinocyte growth factor and its receptor in rats: a key to esophageal ulcer healing? Gastroenterology 122:458–468, 2002
The Molecular and Cellular Biology of Wound Repair. 2nd Edn. RAF Clark (ed). Plenum Press, New York, 1996
Tarnawski A, Hollander D, Krause WJ, Dabros W, Stachura J, Gergely H: “Healed” experimental gastric ulcers remain histologically and ultrastructurally abnormal. J Clin Gastroenterol 12(Suppl 1):139–147, 1990
Tarnawski A, Stachura J, Krause WJ, Douglass TG, Gergely H: Quality of gastric ulcer healing—a new, emerging concept. J Clin Gastroenterol 13(1):S42–S47, 1991
Vanwijck R: Surgical biology of wound healing. Bull Mem Acad R Med Belg 56(3–4):175–184, 2001
Taupin D, Wu D-C, Jeon W-K, Devaney K, Wang TC, Podolsky DK: The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor-and MAP kinase-dependent interregulation. J Clin Invest 103:R31–R38, 1990
Wong WM, Playford RJ, Wright NA: Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy? Gut 46:286–292, 2000
Tarnawski A, Stachura J, Durbin T, Sarfeh IJ, Gergely H: Increased expression of epidermal growth factor receptor during gastric ulcer healing rats. Gastroenterology 102:695–698, 1992
Wright NA, Pike C, Elia G: Induction of a novel epidermal growth factor-secreting cell lineage mucosal ulceration in human gastrointestinal stem cells. Nature 343:82–85, 1990
Tarnawski A, Jones K: The role of EGF and its receptor in mucosal protection, adaptation to injury and ulcer healing. Involvement of EGF-R signal transduction pathways. J Clin Gastroenterol 27:S12–S20, 1998
Okamoto R, Yajima T, Yamazaki M, Kani T, Mukai M, Okamoto S, Ikeda Y, Hibi T, Inazawa J, Watanabe M: Damaged epithelial regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nature Med 8:1011–1017, 2002
Chai J, Baatar D, Tarnawski AS: Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology 126:1809–1818, 2004
Stossel TP: On the crawling of animal cells. Science 260:1986–1994, 1993
Schliwa M: The cytoskeleton. Vienna New York, Springer, 1986, p 326
Polk DB: Epithelial growth factor receptor stimulated intestinal epithelial cell migration requirements phospholipase C activity. Gastroenterology 114:493–502, 1998
Bornfeldt KE, Rainses EW, Graves LM, Skinne MP, Krebs EG, Ross R: Platelet derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann NY Acad Sci 766:416–430, 1995
Pai R, Ohta M, Itani RM, Sarfeh IJ, Tarnawski AS: Induction of mitogen activated protein kinase signal transduction pathway during gastric ulcer healing in rat model. Gastroenterology 114:706–713, 1998
Tarnawski A, Pai R: Translocation of MAP (ERK-1 and -2) kinases to cell nuclei and activation of c-fos gene during healing of experimental gastric ulcer. J Physiol Pharmacol 49:479–487, 1998
Pai R, Jones MK, Tomikawa M, Tarnawski AS: Activation of Raf-1 during experimental gastric ulcer healing is ras-mediated and protein kinase C-independent. Am J Pathol 155:1759–1766, 1999
Tarnawski A, Hollander D, Stachura J, Gergely H, Krause WJ, Sarfeh IJ: Role of angiogenesis in healing of experimental gastric ulcer. In Mechanisms of Peptic Ulcer Healing. F Halter, A Garner, GNJ Tytgat (eds). Dordrecht/Boston/London, Kluwer, 1991, pp 165–171
Risau W: Mechanisms of angiogenesis. Nature 386:671–73, 1997
Folkman J, D'Amore PA: Blood vessel formation: what is its molecular basis? Cell 87:1153–1155, 1996
Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611, 2004
Chai J, Baatar D, Tarnawski AS: Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis: insight into the mechanisms. FASEB J 18:1264–1266, 2004
Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y: Duodenal ulcer. Discovery of a new mechanisms and development of angiogenic therapy that accelerates healing. Ann Surg 214:414–427, 1991
Szabo S, Folkman J, Vattay P, et al.: Accelerated healing of duodenal ulcers by oral administration of basic fibroblast growth factors in rats. Gastroenterology 106:1106–1111, 1994
Szabo S, Folkman J, Vincze A, Sandor ZS, Gombos A: Modulation of vascular factors by VEGF/VPF is sufficient for chronic ulcer healing and acute gastroprotection. Gastroenterology 122:A303, 1997
Jones MK, Itani RM, Wang H, Tomikawa S, Sarfeh IJ, Szabo S, Tarnawski A: Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury. Am J Physiol 276(39):G1345–G1355, 1999
Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS: Inhibition of angiogenesis by NSAIDs. Insight into the mechanisms and implications for cancer growth and ulcer healing. Nature Med 5:1418–1423, 1999
Davis S, Aldrich TH, Jones PF, et al.: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161–1169, 1996
Suri C, Jones PF, Patan S, et al.: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171–1180, 1996
Maisonpierre PC, Suri C, Jones PF, et al.: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60, 1997
Procopio WN, Pelavin PI, Lee WMF, Yeildong NM: Angiopoietin-1 and -2 coiled coil domains mediate distinct oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J Biol Chem 274:30196–30201, 1999
Oh H, Takagi H, Suzuma K, Otani A, et al.: Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274:15723–15739, 1997
Tarnawski A, Pai R, Jones MK, Szabo I, Sarfeh IJ: Gastric ulceration triggers activation of angiopoietin-1, -2 and Tie2 important for angiogenesis. Gastroenterology 118:A242, 2000
Wen CY, Ito M, Chen L-D, Matsuu M, Shichijo K, Nakayama T, Nakashima M, Xu Z-M, Ohtsuru A, Hsu C-T, Sekine I: Expression of Tie-2 and angiopoietin-1 and -2 in early phase of ulcer healing. J Gastroenterol 38:431–435, 2003
Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt AB, Dixit V, Ferrara N: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 13;273(46):30336–30343, 1998
Basson MD, Modlin IM, Turowski G, Madri JA: Enterocyte-matrix interactions in the healing of mucosal injury. Euro J Gastroenterol Hepatol 5(Suppl 3):S21–S28, 1993
Basson MD: In vitro evidence for matrix regulation of intestinal epithelial biology during mucosal healing. Life Sci 69:3005–3018, 2001
Shanin M, Konturek JW, Pohle T, Schuppan D, Herbst H, Domschke W: Remodeling of extracellular matrix in gastric ulceration. Microsc Res Technol 53(6):396–408, 2001
Calabro A, Grappone C, Pellegrini G, Evangelista S, Tramontana M, Schuppan D, Herbst H, Milani S: Spatial and temporal pattern of expression of interstitial collagenase, stromelysin/transin, gelatinase A, and TIMP-1 during experimental gastric ulcer healing. Digestion 70:127–138, 2004
Pai R, Wyle FA, Cover TL, Itani RM, Tarnawski A: H. pylori culture supernatant interferes with EGF-activated signal transduction in human gastric Kato III cells. Am J Pathol 152:1617–1624, 1998
Tarnawski AS, Jones MK: Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. J Mol Med 81:627–636, 2003
Schmassmann A, Tarnawski A, Flogerzi B, Sanner M, Varga Halter LF: Antacids in experimental gastric ulcer healing: pharmacokinetics of aluminum and quality of healing. Eur J Gastroenterol Hepatol 5(3):S14–S16, 1993
Tarnawski A, Arakawa Kobayashi TK: Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa. The key mechanisms for its ulcer healing action? Dig Dis Sci 43(9):90S–98S, 1998
Arakawa T, Nebiki H, Uchida T, Kimura S, Higuchi K, Kobayashi K: Clinical assessment of quality of ulcer healing: a new endoscopic approach. Eur J Gastroenterol Hepatol 5:S87–S92, 1993
Jones MK, Kawanaka H, Baatar D, Szabo IL, Pai, R, Koh GY, Kim I, Sarfeh IJ, Tarnawski AS: Gene therapy for gastric ulcers. With single local injection of VEGF naked DNA encoding VEGF and angiopoietin-1. Gastroenterology 121:1040–1047, 2001
Baatar D, Jones MK, Tsugawa K, Koh Gy, Kim I, Kitano S, Tarnawski AS: Esophageal ulceration triggers expression of hypoxia-inducible factor-1α and activates vascular endothelial growth factor gene. Am J Pathol 161:1449–1457, 2002
Szabo S, Deng X, Khomenko T, Yoshida M, Jadus MR, Sandor Z, Gombos Z, Matsumoto H: Gene expression and gene therapy in experimental duodenal ulceration. J Physiol Paris 95(1–6):325–335, 2001
Deng X, Szabo S, Khomenko T, Jadus MR, Yoshida M: Gene therapy with adenoviral plasmids or naked DNA of VEGF PDGF accelerates healing of duodenal ulcer in rats. J Pharmacol Exp Ther 311:982–988, 2004
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tarnawski, A.S. Cellular and Molecular Mechanisms of Gastrointestinal Ulcer Healing. Dig Dis Sci 50 (Suppl 1), S24–S33 (2005). https://doi.org/10.1007/s10620-005-2803-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2803-6